Cargando…
Fluvoxamine for blonanserin-associated akathisia in patients with schizophrenia: report of five cases
BACKGROUND: Atypical antipsychotic drugs have been reported to cause fewer incidences of extrapyramidal side effects (EPS) than typical antipsychotic drugs, but adverse events such as akathisia have been observed even with atypical antipsychotic drugs. Although understanding of the pathophysiology o...
Autores principales: | Furuse, Tsutomu, Hashimoto, Kenji |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868038/ https://www.ncbi.nlm.nih.gov/pubmed/20416096 http://dx.doi.org/10.1186/1744-859X-9-17 |
Ejemplares similares
-
Fluvoxamine for aripiprazole-associated akathisia in patients with schizophrenia: a potential role of sigma-1 receptors
por: Furuse, Tsutomu, et al.
Publicado: (2010) -
Benefical Effects of Sigma-1 Agonist Fluvoxamine for Tardive Dyskinesia and Tardive Akathisia in Patients with Schizophrenia: Report of Three Cases
por: Albayrak, Yakup, et al.
Publicado: (2013) -
Sigma-1 receptor agonist fluvoxamine for delirium in intensive care units: report of five cases
por: Furuse, Tsutomu, et al.
Publicado: (2010) -
Sigma-1 receptor agonist fluvoxamine for postoperative delirium in older adults: report of three cases
por: Furuse, Tsutomu, et al.
Publicado: (2010) -
Sigma-1 receptor agonist fluvoxamine for delirium in patients with Alzheimer's disease
por: Furuse, Tsutomu, et al.
Publicado: (2010)